Status:

COMPLETED

A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods

Lead Sponsor:

Emory University

Conditions:

Contraception

Eligibility:

FEMALE

13-45 years

Brief Summary

This study will assess the continuation rates among women using oral contraceptive pills, Depo-Provera and Ortho Evra following a first trimester abortion.

Detailed Description

Unintended pregnancy rates among women in the United States continue to surpass that of the rest of the developed world at great cost to society. Contraceptive failure has been attributed to poor comp...

Eligibility Criteria

Inclusion

  • Age 13-45 women presenting at the ambulatory surgery at Grady Memorial Hospital who want to use either oral contraceptive pills, ortho evra or depo provera?

Exclusion

  • Leaving the Atlanta area within 6 months?
  • Desires pregnancy within the next 6 months?
  • Unable to provide contact information?
  • Contraindications to hormonal contraceptive?

Key Trial Info

Start Date :

October 1 2004

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2005

Estimated Enrollment :

321 Patients enrolled

Trial Details

Trial ID

NCT00253019

Start Date

October 1 2004

End Date

November 1 2005

Last Update

August 21 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Grady Memorial Hospital

Atlanta, Georgia, United States, 30303